A significant milestone was reached for both the nation of Peru and the Global Parkinson’s Genetics Program (GP2).
Peru’s Instituto Nacional de Ciencias Neurológicas celebrated the opening of its DNA biobank, the first of its kind in Peru. The biobank will serve as a repository for genetic samples, implementing a system and standards for the use of genetic information for research at the Institute as well as other national and international collaborators.
Development of the DNA biobank was made possible with support from ASAP, the Michael J. Fox Foundation, and LARGE-PD. With the infrastructure portion of the bank nearly complete, ASAP helped commemorate the opening ceremony virtually with colleagues in Peru.
ASAP—through its Global Parkinson’s Genetics Program—seeks to understand the genetics that contribute to PD in Latin America and around the world. The DNA biobank marks an important step to facilitate Parkinson’s disease research in-country and helps ASAP and partners get closer to the goal of global representation for GP2 research.
Learn more about GP2 and submit a cohort here.
